Even other authors considered GSK3β as a tumor suppressor in CLL, as they showed that GSK3β inactivation by a deregulated SYK/PKCδ pathway stabilized the antiapoptotic Mcl-1 protein [59]. This evidence concerns the gene PRKCD and B-cell chronic lymphocytic leukemia.